By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex today said its first-quarter revenues spiked 30 percent year over year, led by record consumables sales.

The Austin, Texas-based molecular diagnostics and multiplex test technologies firm said that revenues rose to $43.3 million for the three months ended March 31, compared to $33.3 million in the first quarter of 2010, exceeding Wall Street expectations of $39.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.